Early detection of blood clotting problems in septic shock
Part of Blood & lymphatic, Infections clinical trials.
This study looks for early signs of dangerous blood clotting complications (called DIC) in patients admitted to intensive care with severe infection. Finding these signs early may help doctors treat the problem faster and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are in intensive care with septic shock (severe infection causing organ failure)
- You have French social security coverage or equivalent health rights
- You or a relative can give consent, or you can be enrolled under emergency procedures if you cannot communicate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special blood test can help doctors quickly identify patients who have serious infections (sepsis) in the emergency department. The test looks at white blood cells that glow under fluorescent light to see if they can predict which patients are at highest risk.
This trial tests if the drug Sivelestat can help people in the intensive care unit who have septic shock and a specific type of blood clotting problem. It aims to improve survival and recovery.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This study checks whether information collected routinely in the ICU can help doctors recognize sepsis or septic shock earlier. If it works, it may improve how quickly diagnosis happens and potentially outcomes for patients.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.